Mesoblast (MESO) Finished Goods (2025)

Mesoblast's (MESO) quarterly Finished Goods came in at $21.2 million in Q2 2025.

Mesoblast (MESO) Finished Goods (2025) Analysis & Trends

Mesoblast has disclosed Finished Goods across 1 years of filings, most recently posting $21.2 million for Q2 2025.

Finished Goods for Q2 2025 came in at $21.2 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $21.2 million (changed N/A YoY), and the FY2025 annual result was $21.2 million, changed N/A from the prior year.
Finished Goods came in at $21.2 million for Q2 2025 at Mesoblast.
In the past five years, Finished Goods ranged from a high of $21.2 million in Q2 2025 to a low of $21.2 million in Q2 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Mesoblast	21.68 Bn	21.55 Bn	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	21.18 Mn